Mostrando 10 resultados de: 14
Filtros aplicados
Subtipo de publicación
Other(14)
Publisher
Elsevier(3)
Elsevier Doyma(2)
BioMed Central(1)
FERRATA STORTI FOUNDATION(1)
Lippincott Williams & Wilkins(1)
Área temáticas
Enfermedades(13)
Farmacología y terapéutica(5)
Medicina y salud(5)
Cirugía y especialidades médicas afines(2)
Fisiología humana(2)
Área de conocimiento
Enfermedad cardiovascular(5)
Infección(1)
Laboratorio médico(1)
Medicamento(1)
Pediatría(1)
Origen
google(14)
Clinical characteristics and outcomes of invasively ventilated patients with COVID-19 in Argentina (SATICOVID): a prospective, multicentre cohort study
OtherAbstract: Background Although COVID-19 has greatly affected many low-income and middle-income countries, detaiPalabras claves:Autores:Dayi SanchezFuentes:googleComparison of international normalized ratio audit parameters in patients enrolled in GARFIELD‐AF and treated with vitamin K antagonists
OtherAbstract: Vitamin K antagonist (VKA) therapy for stroke prevention in atrial fibrillation (AF) requires monitoPalabras claves:Autores:Dayi SanchezFuentes:googleDemographic, clinical, and functional determinants of antithrombotic treatment in patients with nonvalvular atrial fibrillation
OtherAbstract: Background This study assessed the sociodemographic, functional, and clinical determinants of antithPalabras claves:Autores:Dayi SanchezFuentes:googleAplasia pura de células rojas adquirida secundaria a carbamazepina
OtherAbstract: Aplasia pura de células rojas adquirida secundaria a carbamazepina [Rev Clínic Esp.2008]-Medes × CuaPalabras claves:Autores:Dayi SanchezFuentes:googleFactores asociados al mal control de la anticoagulación con antivitamina K en pacientes con fibrilación auricular no valvular atendidos en consultas de Medicina Interna y …
OtherAbstract: Objetivo Identificar los factores asociados con el mal control de la anticoagulación con antagonistaPalabras claves:Autores:Dayi Sanchez, IVAN XAVIER LEON RODRIGUEZFuentes:googleFactors associated with poor anticoagulation control with vitamin K antagonists among outpatients attended in internal medicine and neurology. The ALADIN study
OtherAbstract: Objetivo Identificar los factores asociados con el mal control de la anticoagulación con antagonistaPalabras claves:Autores:Dayi Sanchez, IVAN XAVIER LEON RODRIGUEZFuentes:googleEvolocumab Is Mainly Prescribed In Fh Patients With/Without Atherosclerotic Cardiovascular Disease (Ascvd) In Lipid/Internal Medicine Units In Spain: A Retrospective …
OtherAbstract: Methods: Retrospective, observational, chart review of consecutive patients initiating evolocumab (FPalabras claves:Autores:Dayi SanchezFuentes:googleEarly risks of death, stroke/systemic embolism, and major bleeding in patients with newly diagnosed atrial fibrillation: results from the GARFIELD-AF registry
OtherAbstract: Background: Atrial fibrillation is associated with increased risks of death, stroke/systemic embolisPalabras claves:Autores:Dayi SanchezFuentes:googleP-110: Bone marrow toxicity secondary to primary infection by Epstein–Barr virus in a patient with Crohn’s disease treated with thiopurines
OtherAbstract: P-110: Bone marrow toxicity secondary to primary infection by Epstein–Barr virus in a patient with CPalabras claves:Autores:Dayi SanchezFuentes:googleP-113: Comparative efficacy of mesalamine and azathioprine in pediatric ulcerative colitis after steroid-induced remission at diagnosis
OtherAbstract: P-113: Comparative efficacy of mesalamine and azathioprine in pediatric ulcerative colitis after stePalabras claves:Autores:Dayi SanchezFuentes:google